OAKLAND — The Clorox Company has announced the acquisition of Aplicare Inc. and HealthLink, leading providers of infection control products for the health care industry, according to a press release.
Both acquisitions are important steps in the company''s effort to increase exposure to faster-growing categories as part of an ongoing portfolio transformation, the release stated.
According to the release, the acquisitions complement and expand the breadth and depth of the health care portfolio of Clorox Professional Products Company.
"One element of our strategy is making targeted, strategic acquisitions to drive faster growth. Aplicare and HealthLink build on the success of our 2010 Caltech acquisition, which has strengthened our leadership in bleach-based hard surface disinfection in hospitals," said Clorox Chairman and Chief Executive Officer (CEO) Don Knauss.
"These transactions reinforce the company''s commitment to meet the unique needs of the health care industry, where the use of infection control products is growing rapidly in response to increased attention on helping prevent health care-associated infections," Knauss added.
Aplicare Inc. specializes in developing and manufacturing different forms of products for helping prevent skin infection from needles or surgery, the release noted.
HealthLink bundles a wide assortment of products for use by individual physicians, doctors'' offices, outpatient care centers and other health care facilities, the release added.
Click here to read the complete release.